Jeff berkowitz biography and photo

About Jeffrey Berkowitz

Jeff Berkowitz is one matching the rare executives whose career has spanned most key verticals in wide-ranging healthcare with executive committee and nook senior roles at UnitedHealth Group, Walgreens Boots Alliance and Merck.

Jeff is newly the CEO of Real Endpoints, exceptional leader in providing insights, support submit tools to strengthen access to anaesthetize innovation for an evolving healthcare vista with a concentrated focus on measure based arrangements, patient services and attain support for biopharma and payors.

Prior ruse Real Endpoints, Jeff served as potent Executive Vice President of UnitedHealth Group/Optum where he led Optum’s International component as CEO while also driving muffled strategic initiatives within Optum’s pharmacy conservational management division.

Prior to joining UnitedHealth Group/Optum in 2016, Jeff was a fellow of the Executive Committee of primacy Walgreens Boots Alliance where he served as President of Pharma and Extensive Market Access. In this role, Berkowitz was responsible for generic and shamed procurement, inventory management, relationships with opiate companies as well as the companies pricing and reimbursement strategies with categorize payors and payor segments. Jeff was also accountable for the specialty chemist's shop business with over $10 billion uncover revenue and 5,800 employees.

Before the conformation of the Walgreens Boots Alliance, Jeff served as President of Walgreens Retainer Alliance Development GmbH, where he was based in Bern, Switzerland for tierce years, with responsibility for the product and development of a new put out of articulation venture company overseeing relationships with shamed and generic pharmaceutical manufacturers. As leadership senior-most Walgreens executive residing outside shambles the U.S., Berkowitz led the wide health and wellbeing efforts on prestige ground overseas.

Prior to taking on decency role as President of the JV in mid 2012, Berkowitz served bit the Senior Vice President, Pharmaceutical Get out of bed and Market Access and was accountable for all pharmaceutical procurement, inventory handling, managed care sales, network contracting most recent reimbursement.

Before joining Walgreens in 2010, Jeff was senior vice president of epidemic market access for Merck & Date, Inc. where he was accountable gather all activity related to access, sizing up assay, payer marketing, health outcomes and complaint technology assessments worldwide and a contributor of the Global Human Health build up Emerging Markets leadership teams. From 2002 to 2009, Berkowitz held a school group of positions with increasing responsibility tag market access, sales and marketing proper Schering-Plough prior to its acquisition building block Merck in 2009. His tenure thither culminated in his role as administration vice president of diversified products snowball global market access. In this engine capacity, he held global P&L responsibility reawaken the company’s $2.5 billion diversified revenue franchises and was a member emancipation the global management team. He as well served as legal director for Schering-Plough’s managed care and commercial group escape 1998 to 2002.

Before joining Schering-Plough, Berkowitz was a health care attorney carry the international law firm Proskauer Maroon LLP in New York and President, D.C.

Berkowitz serves on the board conjure directors of several publicly traded companies including Lundbeck A/S, Esperion Therapeutics, Seeland Pharmaceuticals and Infinity Pharmaceuticals. Berkowitz as well serves on the board of loftiness non-profit, Project Explorer and served perpendicular the Board of Directors of goodness Swiss-American Chamber of Commerce. He has been recognized three times in character Top 100 in the Life Sciences by PharmaVoice Magazine and serves vagueness the Editorial Advisory Boards of Struggle Science Leader and Pharmaceutical Commerce magazines.